Taysha Gene Therapies, Inc. (TSHA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -40.88M | -26.72M | -24.17M | -20.18M | -22.02M | -18.31M | -21.61M | -21.5M | -19.8M | -16.12M | -17.95M | -18.77M | -20.18M | 14.28M | -28.81M | -33.35M | -40.94M | -40.26M | -31.93M | -22.82M |
| Operating CF Margin % | - | -487.18% | - | -1016.21% | -956.56% | -905.44% | -1208.89% | -1933.81% | -580.42% | -447.2% | -378.19% | -783.59% | -428.92% | 570.62% | - | - | - | - | - | - |
| Operating CF Growth % | -85.64% | -45.96% | -11.8% | 6.15% | -11.22% | -13.59% | -20.42% | -14.58% | 1.92% | -212.89% | 37.7% | 43.73% | 50.69% | 135.46% | 9.78% | -46.18% | -85.79% | -102.83% | -375.48% | -825.22% |
| Net Income | -42.41M | -27.85M | -32.73M | -26.88M | -21.53M | -18.79M | -25.52M | -20.93M | -24.06M | 47.74M | -117.09M | -24.6M | -17.62M | -55.72M | -26.53M | -34.09M | -50.32M | -50.39M | -51.19M | -40.93M |
| Depreciation & Amortization | 295K | 299K | 433K | 277K | 283K | 304K | 294K | 322K | 325K | 366K | 331K | 343K | 331K | 364K | 277K | 273K | 260K | 209K | 166K | 85K |
| Stock-Based Compensation | 0 | 3.53M | 3.29M | 3.19M | 3.29M | 3.22M | 3.36M | 3.33M | 3.2M | 1.97M | 2.04M | 2.22M | 1.68M | 4.1M | 4.47M | 4.14M | 5.33M | 4.96M | 5.09M | 4.55M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.93M | 101.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.89M | 4.37M | -1.13M | 1.01M | 488K | -442K | 6.14M | 52K | 442K | -57.41M | 3.07M | 4.06M | 428K | 38.02M | 614K | 530K | 1.75M | 2.94M | 1.51M | 194K |
| Working Capital Changes | -4.65M | -7.07M | 5.98M | 2.23M | -4.56M | -2.6M | -5.88M | -4.28M | 298K | -4.85M | -7.37M | -796K | -5M | 27.51M | -7.64M | -4.21M | 2.04M | 2.03M | 12.5M | 13.28M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.29M | -2.13M | 0 | 3M | 923K | -1.5M | -3.78M | -1.61M | 3.98M | -1.23M | -3.19M | 1.76M | 359K | -4.59M | -9.43M | 3.67M | 2.54M | -1.51M | 13.62M | 510K |
| Cash from Investing | -3.02M | -247K | -48K | 62K | -371K | 13K | -35K | -201K | -140K | -10K | -3.49M | 48K | -3.9M | -2.37M | -3.02M | -8.11M | -11.43M | -8.52M | -4M | -8.5M |
| Capital Expenditures | -3.02M | -250K | -108K | -2K | -378K | 2K | -35K | -201K | -140K | -17K | -3.5M | 48K | -3.9M | -2.31M | -2.02M | -7.86M | -8.43M | -8.27M | -3.5M | -3M |
| CapEx % of Revenue | - | 4.56% | - | 0.1% | 16.42% | 0.1% | 1.96% | 18.08% | 4.1% | 0.47% | 73.75% | 2% | 82.87% | 92.29% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 3K | 60K | 64K | 7K | 11K | 0 | 0 | 0 | 7K | 10K | 0 | 0 | -61K | -1M | -250K | -3M | -250K | -500K | -5.5M |
| Cash from Financing | 711K | 49.56M | 8.8M | 216.29M | -52K | -357K | 6.59M | 70.47M | -22K | -4.25M | 140.63M | 377K | -370K | 41.67M | -103K | 11.07M | -107K | 9.11M | 29.98M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.98M | 29.98M | 0 |
| Equity Issued (Net) | 692K | 49.61M | -173K | 216.17M | 75K | -360K | 6.66M | 70.48M | 0 | -423K | 140.71M | 0 | 0 | 41.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -173K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 19K | -57K | 8.97M | 118K | -127K | 3K | -64K | -13K | -22K | 24K | -79K | 377K | -370K | 63K | -103K | 11.07M | -107K | -874K | 0 | 0 |
| Net Change in Cash | -43.19M | 22.59M | -15.42M | 196.17M | -22.44M | -18.65M | -15.05M | 48.76M | -19.96M | -20.38M | 119.19M | -18.34M | -24.45M | 53.57M | -31.93M | -30.39M | -52.47M | -39.67M | -5.96M | -31.31M |
| Free Cash Flow | -40.9M | -26.97M | -24.27M | -20.18M | -22.4M | -18.31M | -21.65M | -21.7M | -19.94M | -16.13M | -21.45M | -18.72M | -24.09M | 11.97M | -31.83M | -41.47M | -52.37M | -48.78M | -35.94M | -31.31M |
| FCF Margin % | - | -491.74% | - | -1016.31% | -972.98% | -905.34% | -1210.85% | -1951.89% | -584.52% | -447.67% | -451.94% | -781.59% | -511.79% | 478.34% | - | - | - | - | - | - |
| FCF Growth % | -82.61% | -47.34% | -12.12% | 7.01% | -12.34% | -13.46% | -0.94% | -15.95% | 17.22% | -234.81% | 32.61% | 54.86% | 54.01% | 124.54% | 11.42% | -32.42% | -132.03% | -88.34% | -432.61% | -1169.83% |
| FCF per Share | -0.11 | -0.08 | -0.07 | -0.07 | -0.08 | -0.09 | -0.08 | -0.09 | -0.09 | -0.09 | -0.17 | -0.29 | -0.38 | 0.21 | -0.78 | -1.03 | -1.37 | -1.28 | -0.95 | -0.84 |
| FCF Conversion (FCF/Net Income) | 0.96x | 0.96x | 0.74x | 0.75x | 1.02x | 0.97x | 0.85x | 1.03x | 0.82x | -0.34x | 0.15x | 0.76x | 1.15x | -0.26x | 1.09x | 0.98x | 0.81x | 0.80x | 0.62x | 0.56x |
| Interest Paid | 0 | 0 | 1.36M | 0 | 1.29M | 1.3M | 1.32M | 1.33M | 1.33M | 1.29M | 1.27M | 1.27M | 1.13M | 1.02M | 823K | 516K | 419K | 531K | 110K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |